Stockscreener 앱 받기
103.96
2.88%
-3.08
시간 외 거래:
103.96
Merit Medical Systems Inc 주식(MMSI)의 최신 뉴스
Which GCs Sold Stock In March? Broadcom, Meta And More - Law360
Biopsy Devices Market Projected To Witness Massive Growth, - openPR.com
3 Reasons to Avoid MMSI and 1 Stock to Buy Instead - Yahoo Finance
Merit Medical Systems COO Neil Peterson sells shares for $522,650 By Investing.com - Investing.com South Africa
Merit Medical Systems COO Neil Peterson sells shares for $522,650 - Investing.com India
How Do Investors Really Feel About Merit Medical Systems? - Benzinga
Percutaneous Drainage Catheters Market Outlook 2024-2031: Top - openPR.com
(MMSI) Investment Report - news.stocktradersdaily.com
Brachytherapy Market Is Expected to Generate USD 1.6 Billion - openPR.com
Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now - Nasdaq
Vanguard Group Inc. Buys 63,314 Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) - MarketBeat
Is Now An Opportune Moment To Examine Merit Medical Systems, Inc. (NASDAQ:MMSI)? - simplywall.st
JPMorgan starts Merit Medical with Overweight, $120 target By Investing.com - Investing.com Australia
This Merit Medical Systems Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Assessing Merit Medical Systems: Insights From 12 Financial Analysts - Benzinga
JPMorgan Initiates Merit Medical Systems at Overweight With $120 Price Target - MarketScreener
JPMorgan starts Merit Medical with Overweight, $120 target - Investing.com India
Updated ASGE Clinical Practice Guideline Includes TIF 2.0 and cTIF for Management of GERD - The Manila Times
Major Breakthrough: Merit Medical's GERD Solution Achieves 94% Success in New Guidelines - Stock Titan
Merit Medical Stock May Rise as WRAPSODY CIE Shows Strong Results - Zacks Investment Research
Merit Medical releases 12-month efficacy results of WRAPSODY WAVE trial - TipRanks
Advancements In Peripheral Support Catheters Driving The Market: Key Trend Transforming the Transradial Acc... - WhaTech
Merit Medical Announces 12-Month Efficacy Results For WRAPSODY CIE In Hemodialysis Patients - Nasdaq
Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE) - The Manila Times
Merit Medical Systems Reports Promising Six-Month and Twelve-Month Results for WRAPSODY CIE in WAVE Trial - Nasdaq
Merit Medical's WRAPSODY Achieves 70% Success Rate vs 41% Standard Treatment - Stock Titan
Medical Devices & SuppliesCardiology, Neurology, Vascular Stocks Q4 Earnings: ICU Medical (NASDAQ:ICUI) Best of the Bunch - Yahoo Finance
(MMSI) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Biopsy Devices Market Generated Opportunities, Future Scope - openPR
Prostatic Artery Embolization Market Is Booming Worldwide - openPR
Merit Medical Systems, Inc. Rings the Opening Bell - Nasdaq
Merit Medical Systems, Inc. Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Merit Medical Rings Nasdaq Opening Bell to Celebrate 35-Year Partnership - The Manila Times
U.S. Uterine Fibroid Treatment Market Future Business - openPR
Major Trend In The Procedure Trays Global Market 2025-2034: Innovative Solutions For Patient Safety Merit M... - WhaTech
Gastrointestinal Stent Market Booms with 6.0% CAGR Growth | TOP - openPR
Merit Medical: A Success Story That Keeps Getting Better - Seeking Alpha
MMSI Announces Commencement of Patient Enrollment in PREEMIE Study - Yahoo Finance
Interventional Neuroradiology Market Expansion: From $1.9B - openPR
Charles Schwab Investment Management Inc. Boosts Holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI) - Defense World
Operating Procedure Trays Market: Key Drivers and Market - openPR
Merit Medical enrols first subject in trial of Bloom Micro Occluder System - Yahoo Finance
First patient enrolled in Merit Medical occluder system study - Mass Device
First Patient Enrolled in Merit Medical's PREEMIE Study - The Manila Times
Merit Medical Begins Clinical Trial for Groundbreaking Premature Baby Heart Treatment - StockTitan
Merit Medical Systems, Inc. to Host Earnings Call - ACCESS Newswire
Insider Selling: Merit Medical Systems, Inc. (NASDAQ:MMSI) CEO Sells $3,252,895.20 in Stock - Defense World
Insider Selling: Merit Medical Systems, Inc. (NASDAQ:MMSI) Insider Sells $3,087,000.00 in Stock - Defense World
Merit Medical Systems, Inc. (NASDAQ:MMSI) Shares Purchased by Edgestream Partners L.P. - MarketBeat
Hedge Fund and Insider Trading News: Steven Cohen, Christer Gardell, Boaz Weinstein, Rokos Capital Management, Silver Point Capital, Starboard Value, Graham Capital Management, Triata Capital, Walker & Dunlop Inc (WD), Merit Medical Systems Inc (M - Insider Monkey
Insider Selling: FRED LAMPROPOULOS Unloads $3.56M Of Merit Medical Systems Stock - Benzinga
Strategic Sale: Brian G Lloyd Decides To Exercise Options Worth $1.37M At Merit Medical Systems - Benzinga
Merit Medical Systems CEO Fred Lampropoulos sells $3.56 million in stock - Investing.com Australia
Merit Medical Systems CEO Fred Lampropoulos sells $3.56 million in stock By Investing.com - Investing.com South Africa
Merit Medical Systems’ chief legal officer sells $3.09m in stock - Investing.com Australia
5.94%
1.87%
자본화:
|
볼륨(24시간):